
Patients with zzso zzso multiple sclerosis on the disease zzso therapy of zzso zzso may be experiencing an adverse reaction of zzso at the sites of their subcutaneous zzso The purpose of this study was to complete a full examination of the injection site areas for users of zzso zzso and to examine the relationship between zzso and patient zzso 

zzso zzso users were identified by means of chart zzso Over six months, during regular clinic zzso assessment included a full examination of injection site areas including visual inspection and manual zzso Additional patient and clinical characteristics were obtained by means of chart review and patient zzso 

zzso patients had been or were current users of zzso zzso Of these, 34 zzso had evidence of zzso in at least one injection site zzso All were female, and five had zzso nine had moderate and 20 had mild zzso In some cases, zzso occurred within months of therapy zzso Case reviews are included for five of the 34 patients, along with photographs of the zzso a magnetic resonance image and comments on skin zzso 

zzso of zzso was much higher than zzso zzso reasons for this adverse reaction are explored and suggested treatment recommendations are zzso zzso can be very disfiguring and is thought to be zzso and the psychological impact can be zzso It is, therefore, important that patients be aware of the possibility of zzso be able to identify it and zzso injecting in areas where it is zzso 

